Letter to the Editors
Final analysis of a phase II study of ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma
Dai Maruyama
, Hirokazu Nagai, Noriko Fukuhara, Toshiyuki Kitano, Takayuki Ishikawa, Tomoaki Nishikawa
Author information
Keywords:
covalent BTK inhibitor,
ibrutinib,
Japanese patients,
mantle cell lymphoma,
phase II clinical trial
2019 Volume 59 Issue 2 Pages 98-100
Details
Article 1st page
